CHOE MEDI |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | -.--% |
| Jun. 26 | Chordate Medical Holding AB Receives First Order from Switzerland | CI |
| Jun. 13 | Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG | CI |
| Sales 2022 | 109K 10.29K 9.41K | Sales 2023 | 1.75M 166K 152K | Capitalization | 37.28M 3.54M 3.23M |
|---|---|---|---|---|---|
| Net income 2022 | -27M -2.56M -2.34M | Net income 2023 | -29M -2.75M -2.52M | EV / Sales 2022 | 723 x |
| Net cash position 2022 | 3.68M 349K 319K | Net cash position 2023 | 8.46M 802K 733K | EV / Sales 2023 | 16.5 x |
| P/E ratio 2022 |
-2.89
x | P/E ratio 2023 |
-1.23
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 46.01% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 14-10-31 | |
| Director of Finance/CFO | 56 | 17-10-01 | |
Jan Hermansson
CTO | Chief Tech/Sci/R&D Officer | 68 | 11-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 14-05-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 61 | 17-03-31 |
| Chief Executive Officer | 63 | 14-10-31 |
Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Companyâs headquartered is located in Kista, Sweden.
Calendar
2024-08-30
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +4.74% | 212B | |
| +8.73% | 187B | |
| +26.75% | 155B | |
| +33.92% | 115B | |
| +2.17% | 65.5B | |
| +14.12% | 52.87B | |
| -3.30% | 45.25B | |
| -3.30% | 39.7B | |
| +6.44% | 37.72B |
